Evidence map›Paper›PMID 35480233›Full record

ReviewFrontiers in cellular and infection microbiology2022

Recent Progress Towards a Gonococcal Vaccine.

Stavros A Maurakis, Cynthia Nau Cornelissen

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Genomic analysis ofMicrobiology spectrum · 2026
    Article
  3. Article
  4. Review
  5. Frontiers in microbiology · 2026
    Review
  6. Discovery and characterization of an anti-Frontiers in microbiology · 2026
    Article
  7. Structure-guidedBiochemistry and biophysics reports · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Antibiotic Resistance inMicroorganisms · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Stavros A MaurakisInstitute for Biomedical Sciences, Georgia State University, Atlanta, GA, United States.
Cynthia Nau CornelissenInstitute for Biomedical Sciences, Georgia State University, Atlanta, GA, United States.
Georgia State University · US

Funding

Using gonococcal TonB-dependent transporters as vaccine antigensU19AI144182 · NIAID · GEORGIA STATE UNIVERSITY · PI CORNELISSEN, CYNTHIA N · 2019 to 2023
$9.3M
Neisseria gonorrhoeae metal transporters that subvert nutritional immunityR01AI127793 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CYNTHIA N CORNELISSEN, Alison K Criss · 2017 to 2026
$6.8M
Rational design of transferrin binding protein-based vaccines to combat gonorrheaR01AI125421 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CORNELISSEN, CYNTHIA N, GRAY-OWEN, SCOTT D · 2017 to 2021
$3.1M
Iron acquisition mechanisms utilized by Neisseria gonorrhoeaeR01AI084400 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CORNELISSEN, CYNTHIA N · 2009 to 2010
$674k
NIAID NIH HHS R01 AI084400NIAID NIH HHS R01 AI125421NIAID NIH HHS R01 AI127793NIAID NIH HHS U19 AI144182
6 · The paper itself

Abstract

Gonorrhea is a global health concern. Its etiological agent,

Indexed as

GonorrheaBacterial VaccinesEpitopesHumansNeisseria gonorrhoeaeBacterial VaccinesEpitopescomputationepitopegonorrheaimmunitymodelingNeisseria gonorrhoeaesexually-transmitted infectionsvaccine

Identifiers

PMID35480233
PMCPMC9038166
OpenAlexW4223625416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.